Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

473
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
473
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

148
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
148
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

40
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
40
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

30
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
30
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

35
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
35
Nursing Ethical Principles II01:27

Nursing Ethical Principles II

1.6K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ASPEN survey of parenteral nutrition access issues: How the system fails the patient.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition·2024
Same author

Parenteral nutrition compatibility and stability: Practical considerations.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition·2024
Same author

Parenteral nutrition insecurity: ASPEN survey to assess the extent and severity of parenteral nutrition access and reimbursement issues.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition·2023
Same author

Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial.

The Lancet. Neurology·2023
Same author

Sustainable pathways towards climate and biodiversity goals in the UK: the importance of managing land-use synergies and trade-offs.

Sustainability science·2022
Same author

Update on use of enteral and parenteral nutrition in hospitalized patients with a diagnosis of malnutrition in the United States.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition·2022

Related Experiment Video

Updated: Oct 23, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.8K

Identifying Nutrition Risk in a Charitable Pharmacy Population.

Bethany E Collier, Anna C Felmer, Jay M Mirtallo

    Journal of Health Care for the Poor and Underserved
    |August 23, 2021
    PubMed
    Summary
    This summary is machine-generated.

    A new dual-purpose screening tool identified significant nutrition risk in 63% of patients at a charitable pharmacy. This highlights the need for integrated food insecurity and malnutrition assessments in community health settings.

    More Related Videos

    Determining Gender-Based Differences in Retinal and Choroidal Thickness in Underweight Individuals via Swept-Source Optical Coherence Tomography
    03:35

    Determining Gender-Based Differences in Retinal and Choroidal Thickness in Underweight Individuals via Swept-Source Optical Coherence Tomography

    Published on: December 1, 2023

    413
    Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
    05:35

    Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

    Published on: January 19, 2024

    1.0K

    Related Experiment Videos

    Last Updated: Oct 23, 2025

    A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
    04:53

    A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

    Published on: September 20, 2019

    10.8K
    Determining Gender-Based Differences in Retinal and Choroidal Thickness in Underweight Individuals via Swept-Source Optical Coherence Tomography
    03:35

    Determining Gender-Based Differences in Retinal and Choroidal Thickness in Underweight Individuals via Swept-Source Optical Coherence Tomography

    Published on: December 1, 2023

    413
    Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
    05:35

    Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

    Published on: January 19, 2024

    1.0K

    Area of Science:

    • Community Health
    • Nutrition Science
    • Public Health Policy

    Background:

    • Food insecurity and malnutrition negatively impact health outcomes and increase healthcare costs.
    • Nutrition risk is underassessed in community settings.
    • Existing screening tools address food insecurity or malnutrition individually, not concurrently.

    Purpose of the Study:

    • Implement a dual-purpose screening tool for nutrition risk in a community setting.
    • Characterize nutrition risk within a charitable pharmacy population.
    • Connect at-risk patients to community nutrition resources.

    Main Methods:

    • A dual-purpose screening tool was implemented at the Charitable Pharmacy of Central Ohio.
    • 221 patients were screened during initial and annual qualification interviews.
    • Patients screening positive for nutrition risk were referred to available resources.

    Main Results:

    • 140 out of 221 (63%) patients screened positive for nutrition risk.
    • 84 (38%) screened positive for food insecurity, 14 (6%) for malnutrition risk, and 42 (19%) for both.
    • Patients were referred to food pantries, home-delivered meals, and SNAP.

    Conclusions:

    • A significant portion of patients in a charitable pharmacy setting face nutrition risk.
    • A dual-purpose screening tool effectively identifies individuals with food insecurity and/or malnutrition.
    • Integrated screening and resource referral are crucial for addressing nutrition risk in community health.